The immunomodulatory activity of secnidazole–nitazoxanide in a murine cryptosporidiosis model

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Madbouly N.; El Amir A.; Kader A.A.; Rabee I.; Farid A.

Journal: Journal of Medical Microbiology

Publisher: Microbiology Society

Publication Date: 1 March 2021

Volume / Issue: Volume 70 / Issue 3

Article No.: 1327

ISSN: 222615

DOI: 10.1099/jmm.0.001327

Scopus: View on Scopus

PubMed: 33625354

Document Type: Article


Authors and Affiliations

Madbouly N., Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt; El Amir A., Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt; Kader A.A., Department of Parasitology, Theodore Bilharz Research Institute, Giza, Egypt; Rabee I., Department of Parasitology, Theodore Bilharz Research Institute, Giza, Egypt; Farid A., Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt


Abstract

Introduction. Cryptosporidium parvum causes intestinal parasitic infections affecting both immunosuppressed and immunocompetent individuals. Gap statement. Given the absence of effective treatments for cryptosporidiosis, especially in immunodeficient patients, the present study was designed to assess the therapeutic efficacy of secnidazole (SEC) and its combination with nitazoxanide (NTZ) in comparison to single NTZ treatment in relation to the immune status of a murine model of C. parvum infection. Methodology. The infected groups were administered NTZ, SEC or NTZ–SEC for three or five successive doses. At days 10 and 12 post-infection (p.i.), the mice were sacrificed, and the efficacy of the applied drugs was evaluated by comparing the histopathological alterations in ileum and measuring the T helper Th1 (interferon gamma; IFN-γ), Th2 [interleukin (IL)-4 and IL-10] and Th17 (IL-17) cytokine profiles in serum. Results. The NTZ–SEC combination recorded the maximal reduction of C. parvum oocyst shedding, endogenous stages count and intestinal histopathology, regardless of the immune status of the infected mice. The efficacy of NTZ–SEC was dependent on the period of administration, as the 5 day-based treatment protocol was also more effective than the 3 day-based one in terms of immunocompetence and immunosuppression. The present treatment schedule induced an immunomodulatory effect from SEC that developed a protective immune response against C. parvum infection with reduced production of serum IL-17, IFN-γ, IL-4 and IL-10. Conclusions. Application of NTZ–SEC combined therapy may be useful in treatment of C. parvum, especially in cases involving immunosuppression. © 2021 The Authors.


Keywords

C. parvum; Immunomodulation; Nitazoxanide; Secnidazole; Animals; Antiprotozoal Agents; Cryptosporidiosis; Cryptosporidium parvum; Cytokines; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Ileum; Immunocompromised Host; Male; Metronidazole; Mice; Nitro Compounds; Parasite Load; Thiazoles; amebazole; dexamethasone; dexazone; gamma interferon; interleukin 10; interleukin 17; interleukin 4; nanazoxid; antiprotozoal agent; cytokine; nitro derivative; thiazole derivative; animal experiment; animal model; animal tissue; Article; combination drug therapy; controlled study; cytokine response; developmental stage; drug efficacy; enzyme linked immunosorbent assay; feces analysis; histopathology; immune deficiency; immune response; immunocompetence; monotherapy; mouse; nonhuman; oocyst; priority journal; protein blood level; Th1 cell; Th2 cell; treatment duration; treatment response; animal; blood; disease model; drug administration; drug effect; immunocompromised patient; immunology; parasitology; pathology


Citation Information

Scopus Citations: 13


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]